Core Viewpoint - The announcement details the completion of the transfer of shares from a major shareholder, Shanghai Yueye, following a judicial auction, resulting in a new shareholder holding over 5% of the company's shares [1][2][3]. Group 1: Share Transfer Details - Shanghai Yueye successfully auctioned 124,600,010 shares, representing 5.76% of the company's total share capital, and 5.87% when excluding shares in the company's repurchase account [1][2]. - After the transfer, the new shareholder, Chen Zhiwenlong, holds 109,500,000 shares, which is 5.06% of the total share capital and 5.16% when excluding repurchased shares [3][4]. Group 2: Auction Process - The fifth auction involved 323,800,000 shares, with 124,600,010 shares successfully bid by Chen Zhiwenlong and 12 other individuals, while 199,199,990 shares remained unsold due to lack of bids [1][2]. Group 3: Regulatory Compliance - The auction and share transfer comply with relevant regulations, including the Securities Law and guidelines for shareholder share reductions [4][5]. - The new shareholder, Chen Zhiwenlong, is required to adhere to a six-month restriction on selling the acquired shares following the judicial transfer [4][5]. Group 4: Shareholder Commitments - Shanghai Yueye has made commitments regarding future transactions with the company to avoid conflicts of interest and ensure compliance with market principles [5][6]. - The commitments will remain in effect until the completion of the share disposal by Shanghai Yueye [5][6].
德展健康: 关于持股5%以上股东所持公司股份拍卖过户完成暨新增持股5%以上股东的公告